General Prognostics - GPx

01/18/2023

📣2023 SXSW Pitch Finalist General Prognostics (GPx)📣

Proud of the at for being recognized and selected as one of the five SXSW Pitch Finalists among a group of from across the world🌍

SXSW Pitch is the marquee event of Conference & Festivals (March 10 - 19, 2023). We are honored and grateful for the opportunity to present and share our vision of at !

Congratulations to all the and see you in Austin👋

Explore finalists and alternates announced for the 15th annual SXSW Pitch event from March 11-12 in Austin, TX.

11/15/2022

🏆WE WON 2nd Place in the HLTH Pitch Competition🚀Thank you HLTH and the esteemed judges of the pitch competition (Johnson & Johnson Innovation - Stacy Feld, Able Partners - Alison Ryu, NEXT Ventures - Julian Eison, a16z Bio + Health - Jay Rughani)🙌

We are honored for the opportunity to pitch in front of a great audience and important event🎉

10/13/2022

Guess who's a finalist for the pitch competition? ! We can't wait to present to the judges alongside with other amazing and innovative on November 14th. Thank you HLTH for the opportunity to showcase the world's first as we work to eradicate preventable readmission!

10/05/2022

Very pleased to get top-tier coverage for GPx's news with Crunchbase News and additionally by StrictlyVC. Thank you Connie Loizos and StrictlyVC!

, ,

10/05/2022

Congratulations to Dr. Shah, Eva Adams, Kartik Munshi, and the team at University of Kansas Medical Center for the continued success on enrolling their CardioID patients into .

We are grateful for your continued support in the development of !

10/03/2022

We've got huge news! We are incredibly excited to announce our funding round with support from incredible investors such as Peter Moran (former long-time GP of DCM Ventures), Hiroaki Kitano (CTO of Sony Group Corporation), Masao Hitotsuyanagi (former President of Terumo Cardiovascular), and Tom Kelley/D4V (Design for Ventures), alongside with many many investors. Thank you!

We are truly blessed to have employees, investors, partners, and supporters who believe in our vision of developing for cardio renal disease.

We still have a lot of work to do to accelerate the on-going pilot to further train and refine the algorithm but we are excited to continue this journey with you all.

The GPx Tribe deserves a mention - Soumil Chugh, Amit Singh, Kristy Osorez, Farheen Shaikh, Nandini Murthy, Theresa Tribble, Peter Branecky, Andrew J. Sauer, MD, Jim Yearick, John L Brooks III, Yusuke Tsugawa, MD, PhD, Sean Yokomizo.

Medical device startup General Prognostics raised $3.25 million in seed funding to launch a wearable monitoring device. It’s one of several startups diving into remote patient monitoring.

08/02/2022

Join co-founders Javier Echenique and Shunsuke Sean Matsuoka in San Diego on Sept. 8-10th for Heart Rhythm Society's . It is an honor to share our vision of and our mission to eradicate preventable readmission alongside four other amazing startups.

Check out the video from Javier to learn more:

07/10/2022

General Prognostics (GPx) will be presenting at the upcoming Heart Rhythm Society ’s Pitch Competition in San Diego. We are excited about participating in as a way to get feedback from individuals in the industry, form new partnerships, and grow awareness of our bloodless blood test technology. Come and join us!

米国不整脈学会のデジタルヘルスの会合@サンディエゴで行われるピッチコンペティションの決勝に進出しました！

*/

07/10/2022

We are thrilled to announce the appointment of Dr. Yusuke Tsugawa as a strategic advisor to GPx. Dr. Tsugawa is an associate professor of medicine and health policy & management at UCLA. His strategic perspective, thorough understanding of AI. and proven experience advising digital health companies will be valuable assets to guide GPx's algorithm development plan.

“We are excited to welcome Dr. Tsugawa as an advisor. He is a renowned expert in healthcare data and poise us to continue our development strategy that will enable the bloodless blood tests.” said Sean (Shunsuke) Matsuoka.

04/25/2022

Thank you HBS Healthcare Alumni Association and HBS Alumni Angels of Greater New York for the opportunity to present our vision of to the judges and how GPx can help improve outcomes for patients with .

To register: http://www.hbshealthalumni.org/s/1738/cc/21/page.aspx?sid=1738&gid=11&pgid=76712&content_id=108983

04/14/2022

GPx is proud to announce that Jim Yearick has joined the company’s strategic advisory board. Jim is currently the Senior VP of sales and marketing at Endotronix, which is quickly improving the remote monitoring of heart failure patients. He brings over 30 years of medical device and consumer product commercialization experience, and is intimately connected with HF physicians around the world.

"We brought Jim into the company because his deep understanding of our market and medical device strategy will prove invaluable to us as we continue to develop and commercialize CardioID. His involvement will dramatically increase our visibility in the US as well as around the world," says Javier Echenique.